Crusekitug, CAS 2956768-50-4

Product Description: Crusekitug is a humanized monoclonal antibody targeting human interleukin 17A (IL-17A). Crusekitug specifically binds to IL-17A, blocking its signal transduction, thus exerting immunosuppressive and anti-inflammatory activities. Crusekitug is promising for research of autoimmune and inflammatory diseases, such as psoriasis and rheumatoid arthritis[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.

CAS Number: 2956768-50-4

Molecular Weight: N/A

Research Area: Inflammation/Immunology

Target: Interleukin Related

• Artikelnummer: MEXHY-P991129-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P991129-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK
• Konjugat: Unconjugated